BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32885541)

  • 1. Efficacy and tolerability of a cream containing modified glutathione (GSH-C4), beta-Glycyrrhetic, and azelaic acids in mild-to-moderate rosacea: A pilot, assessor-blinded, VISIA and ANTERA 3-D analysis, two-center study (The "Rosazel" Trial).
    Dall'Oglio F; Puviani M; Milani M; Micali G
    J Cosmet Dermatol; 2021 Apr; 20(4):1197-1203. PubMed ID: 32885541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study.
    Bertolani MB; Rodighiero E; Gandolfi M; Lotti T; Pedrazzi G; Puviani M; Milani M; Feliciani C; Satolli F
    Dermatol Ther; 2021 Jan; 34(1):e14724. PubMed ID: 33377285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel azelaic acid formulation for the topical treatment of inflammatory rosacea: A multicentre, prospective clinical trial.
    Dall'Oglio F; Tedeschi A; Lacarrubba F; Fabbrocini G; Skroza N; Chiodini P; Micali G
    J Cosmet Dermatol; 2021 Apr; 20 Suppl 1(Suppl 1):28-31. PubMed ID: 33934475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-center, assessor-blinded, prospective trial evaluating the efficacy of a novel hypertonic draining cream for cellulite reduction: A Clinical and instrumental (Antera 3D CS) assessment.
    Puviani M; Tovecci F; Milani M
    J Cosmet Dermatol; 2018 Jun; 17(3):448-453. PubMed ID: 29205802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
    Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
    J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.
    Taieb A; Ortonne JP; Ruzicka T; Roszkiewicz J; Berth-Jones J; Peirone MH; Jacovella J;
    Br J Dermatol; 2015 Apr; 172(4):1103-10. PubMed ID: 25228137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
    Stein Gold L; Kircik L; Fowler J; Jackson JM; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Sugarman J; Liu H; Jacovella J;
    J Drugs Dermatol; 2014 Nov; 13(11):1380-6. PubMed ID: 25607706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
    Elewski BE; Fleischer AB; Pariser DM
    Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of low molecular weight hyaluronic acid sodium salt 0.2% cream in rosacea.
    Schlesinger TE; Powell CR
    J Drugs Dermatol; 2013 Jun; 12(6):664-7. PubMed ID: 23839183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.
    Gold LS; Papp K; Lynde C; Lain E; Gooderham M; Johnson S; Kerrouche N
    J Drugs Dermatol; 2017 Sep; 16(9):909-916. PubMed ID: 28915286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea.
    Bjerke R; Fyrand O; Graupe K
    Acta Derm Venereol; 1999 Nov; 79(6):456-9. PubMed ID: 10598760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study.
    Schaller M; Dirschka T; Kemény L; Briantais P; Jacovella J
    Dermatol Ther (Heidelb); 2016 Sep; 6(3):427-36. PubMed ID: 27432169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
    Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
    Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
    Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
    Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
    [No Abstract]   [Full Text] [Related]  

  • 17. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
    Chu CY
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety.
    Rosso JQ; Draelos ZD; Effron C; Kircik LH
    J Drugs Dermatol; 2021 Apr; 20(4):426-431. PubMed ID: 33852248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.
    Maddin S
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):961-5. PubMed ID: 10365928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
    Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
    J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.